Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 5c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.34), $0.05 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• HSBC Downgrades Stellantis NV (STLA:IM) (STLA) to Reduce
• Trifecta Gold closes $1.66M private placement for Yukon exploration